CII
AGIO icon

Capital International Inc’s Agios Pharmaceuticals AGIO Stock Holding History

Capital International Inc’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-98,882
Closed -$3.46M – 291
2020
Q3 		$3.46M Buy
98,882
+745
+0.8% +$32.7K 0.04% 197
2020
Q2 		$5.25M Buy
98,137
+31,758
+48% +$1.47M 0.06% 162
2020
Q1 		$2.35M Buy
66,379
+2,782
+4% +$129K 0.04% 165
2019
Q4 		$3.04M Sell
63,597
-301,541
-83% -$11.4M 0.04% 154
2019
Q3 		$11.8M Buy
365,138
+316,861
+656% +$13.1M 0.18% 114
2019
Q2 		$2.41M Buy
48,277
+27,901
+137% +$1.49M 0.17% 114
2019
Q1 		$1.37M Sell
20,376
-1,000
-5% -$58.2K 0.16% 100
2018
Q4 		$986K Hold
21,376
– – 0.13% 116
2018
Q3 		$1.65M Buy
21,376
+6,076
+40% +$489K 0.22% 95
2018
Q2 		$1.29M Sell
15,300
-900
-6% -$78.5K 0.2% 88
2018
Q1 		$1.32M Sell
16,200
-11,350
-41% -$877K 0.19% 90
2017
Q4 		$1.57M Sell
27,550
-13,250
-32% -$834K 0.23% 83
2017
Q3 		$2.72M Sell
40,800
-20,900
-34% -$1.26M 0.4% 60
2017
Q2 		$3.17M Sell
61,700
-24,100
-28% -$1.23M 0.45% 56
2017
Q1 		$5.01M Sell
85,800
-300
-0.3% -$14.4K 0.61% 42
2016
Q4 		$3.59M Buy
86,100
+26,200
+44% +$1.37M 0.45% 57
2016
Q3 		$3.16M Sell
59,900
-5,200
-8% -$226K 0.38% 47
2016
Q2 		$2.73M Buy
65,100
+6,300
+11% +$311K 0.33% 66
2016
Q1 		$2.39M Sell
58,800
-39,100
-40% -$1.67M 0.26% 72
2015
Q4 		$6.36M Buy
97,900
+25,200
+35% +$1.65M 0.56% 51
2015
Q3 		$5.13M Buy
72,700
+8,900
+14% +$870K 0.47% 58
2015
Q2 		$7.09M Sell
63,800
-1,300
-2% -$140K 0.51% 56
2015
Q1 		$6.14M Sell
65,100
-1,500
-2% -$168K 0.46% 61
2014
Q4 		$7.46M Buy
+66,600
New +$5.95M 0.51% 58

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital International Inc's AGIO Position: Q4 2020 in Review

Capital International Inc sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 98,882 shares — an estimated $3.46M sold.

Capital International Inc first reported a position in AGIO in Q4 2014 and held it in 24 quarters. The position peaked at $11.8M in Q3 2019. 200 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Capital International Inc reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Capital International Inc sold 98,882 Agios Pharmaceuticals shares in Q4 2020, an estimated $3.46M.
  • Capital International Inc first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 24 quarters.
  • Capital International Inc's Agios Pharmaceuticals position peaked at $11.8M in Q3 2019.
  • 200 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Capital International Inc's 13F filing for Q4 2020, filed 16 Feb 2021.